NCT03730311View on ClinicalTrials.gov

Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

May 31, 2019

Primary Completion Date

November 30, 2019

Study Completion Date

December 31, 2019

Conditions
HIV Infections
Interventions
DRUG

Elpida

elsulfavirine, capsules

DRUG

placebo

placebo

Trial Locations (1)

Unknown

Siriraj Hospital, Bangkok

Sponsors

Lead Sponsor

Viriom
All Listed Sponsors
lead

Viriom

INDUSTRY

NCT03730311 - Phase Ib Study of Safety, Tolerability and Pharmacokinetics of Elpida Once Weekly in Healthy Volunteers | Biotech Hunter | Biotech Hunter